The present study confirmed the findings that an increase in TNF‐α, IL‐1β and IL‐6 levels, and a reduction of IL‐10 concentration in brain tissues with CIS administration compared to the control group was associated with the triggering of the inflammatory cascade. This evidence concerns the gene IL6 and in situ carcinoma.